GLP-1 receptor agonists cause bloating by slowing gastric emptying, which prolongs food transit through the digestive system and increases gas production
2020, pmc.ncbi.nlm.nih.gov/articles/PMC7503967
Obesity, a growing global health concern, is a risk factor for numerous conditions, including type 2 diabetes, cardiovascular diseases, and certain types of cancer
If you are using a standard pill, you will need to be much stricter about taking it on a completely empty stomach to see any benefit
Oral and topical glutathione may reduce melanin production, leading to mild skin lightening in some people
Clinical evidence supports semaglutide's potential to lower cardiovascular risk in people with T2D along with other cardiovascular disorders